Advertisement
Medtronic
Subscribe to Medtronic
View Sample

FREE Email Newsletter

First Human Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker

December 9, 2013 1:36 pm | by The Associated Press | News | Comments

Continuing its leadership in advanced pacing technology and device miniaturization, Medtronic, Inc., today announced the first-in-human implant of the world's smallest pacemaker: the Micra Transcatheter Pacing System. The device was implanted...

Medtronic Presents First-of-Its-Kind Data Showing Sustained Results with Cervical Disc Replacement After Seven Years

December 6, 2013 10:06 am | by The Associated Press | News | Comments

Medtronic, Inc. presented 7-year clinical and radiographic outcomes of artificial disc replacement with PRESTIGE® Cervical Disc compared to anterior cervical discectomy and fusion (ACDF) yesterday at the Cervical Spine Research Society Annual...

Endurant II AAA Stent Graft from Medtronic Delivers Durable, Consistent, and Proven Outcomes in Real-World Setting

November 26, 2013 10:18 am | by Medtronic | News | Comments

Chosen for nearly one out of every two endovascular abdominal aortic aneurysm (AAA) repairs worldwide, the Endurant II AAA stent graft system from Medtronic, Inc. continues to demonstrate long-term durability and consistent outcomes at three...

Advertisement

Appeals court affirms $10M Medtronic loss in catheter patent case

November 19, 2013 11:00 am | by Mass Device | News | Comments

A federal appeals court dealt a blow to Medtronic yesterday when it upheld a lower court's decision to award $10 million to the physician inventor of a patent involving catheters. The U.S. Court of Appeals for the Federal Circuit affirmed an...

Unexpectedly strong ICD sales for Medtronic buoy Boston Scientific

November 19, 2013 9:59 am | by Mass Device | News | Comments

Medtronic posted stronger-than-expected U.S. sales growth for its implantable cardioverter defibrillators, buoying shares of ICD rival Boston Scientific. Medtronic's U.S. ICD sales grew 3.9% during its fiscal 2014 2nd quarter ended Oct. 25, rising...

Trial Shows Significant Delay in Atrial Fibrillation Disease Progression with Medtronic-Exclusive Pacing Features

November 18, 2013 12:09 pm | by Medtronic | News | Comments

New research shows that Medtronic Inc. pacemakers with enhanced pacing features have the ability to slow the progression of atrial fibrillation (AF) in patients with bradycardia, or a slow heartbeat. Presented as a late breaking clinical trial...

Medtronic Renal Denervation Device Offers Significant Drops in Blood Pressure After Treatment

October 31, 2013 2:39 pm | by Medtronic | News | Comments

Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running randomized, controlled clinical trial of renal denervation, which continue to demonstrate results consistent with data reported previously at six, 12...

Medtronic claims a win in European patent row with Edwards Lifesciences

October 30, 2013 10:58 am | by Mass Device | News | Comments

Medtronic is claiming a win in Europe in its patent row with Edwards Lifesciences over their competing transcatheter aortic valve implants. The European Patent Office issued a preliminary, non-binding ruling that the Edwards patent at the center of a...

Advertisement

Medtronic CoreValve U.S. Pivotal Trial Results Reveal Positive Outcomes for Patients

October 29, 2013 2:25 pm | by Medtronic | News | Comments

Medtronic, Inc. today announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S. data presented on the Medtronic CoreValve® System. The study of the novel self-expanding device, presented at a late-breaking...

TCT 2013: Higher pacemaker rate marks difference between Medtronic's, Edwards Lifesciences' TAVI devices

October 28, 2013 6:28 pm | by Mass Device | News | Comments

Results from the PRAGMATIC Plus analysis of Edwards Lifesciences' Sapien transcatheter aortic valve implantation system and Medtronic's rivaling CoreValve device found few differences between the devices, with the exception of lower rates of...

TCT 2013: Renal denervation does everything

October 28, 2013 4:35 pm | by Mass Device | News | Comments

Renal denervation may have lost some of its hype over the course of the last year, but researchers are still findings new ways to utilize the technology to target new diseases. Technologies such as Medtronic's Symplicity and St. Jude Medical's...

Will preemption rescue Medtronic from InFuse lawsuits?

October 24, 2013 1:27 pm | by Mass Device | News | Comments

Medtronic could avoid a major headache if the courts continue to allow the doctrine of preemption in product liability lawsuits filed over its InFuse bone-growth protein, according to Fish & Richardson principal José Sierra. The InFuse bone growth...

Medtronic Launches New Device to Remove Coronary Thrombus

October 21, 2013 12:01 pm | by Medtronic | News | Comments

With more than a decade of market leadership in medical devices designed to remove thrombus from coronary arteries, Medtronic has announced the U.S. launch of the Export Advance aspiration catheter, which offers ...    

Advertisement

Medtronic can't shake negligence lawsuit over Transvene defibrillator lead

October 16, 2013 3:11 pm | by Mass Device | News | Comments

Medtronic can't use preemption to shake a negligence lawsuit filed over a failed Transvene defibrillator lead, an Indiana appeals court ruled last week. The Court of Appeals of Indiana denied the Fridley, Minn.-based medical device company's bid...

Apollo Hospitals and Medtronic Announce a Collaboration to Bring an Affordable, Portable Hemodialysis System to India

October 9, 2013 5:06 am | by The Associated Press | News | Comments

Apollo Hospitals Enterprise Ltd., one of the leading healthcare providers in Asia, and Medtronic, Inc. (NYSE: MDT), the global leader in medical technology, today announced a collaboration to bring to market an innovative, affordable and portable...

FDA Advisory Panel Recommends Expanded Indication for Medtronic's CRT Devices

October 8, 2013 6:06 pm | by The Associated Press | News | Comments

The U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices Advisory Panel today voted that biventricular (BiV) pacing with Medtronic, Inc. (NYSE: MDT) devices is beneficial for treating patients who have atrioventricular (AV) block...

Independent Study Examines Battery Life in CRT-D Devices

October 8, 2013 5:45 pm | by PR Newswire | News | Comments

An independent and first-of-its-kind study from the University of Pittsburgh Medical Center, published online this week in EP EuroPace, shows there are significant differences in battery longevity between contemporary cardiac resynchronization...

Supreme Court seeks White House opinion in Medtronic pain pump case

October 7, 2013 4:24 pm | by Mass Device | News | Comments

Medtronic has had a lot of action in the courts today, with the Supreme Court sending a negligence lawsuit against the company up to the federal government for a 2nd opinion. The Justices asked the White House to weigh in on a lawsuit that questions preemption laws for medical devices...

With MiniMed 530G, Medtronic Seeks New CMS Code

October 2, 2013 10:53 am | by AB Newswire | News | Comments

Medtronic Diabetes tells Evidenced-Based Diabetes Management that it has applied to CMS for a new code that would cover sensor-augmented insulin pumps, which would broaden Medicare coverage for the new “artificial pancreas” system it unveiled on Friday.

Therapeutic Coatings for Medical Device Implants

October 1, 2013 3:27 pm | by Nathan Lockwood, Ph.D., Senior Manager of R&D, SurModics Inc. | SurModics, Inc. | Articles | Comments

Drug delivery coatings are not a new technology to the medical device industry. However, as more implantable devices are tasked with achieving a greater level of healthcare, they do offer great benefit to design engineers. This article reviews drug coating technology and looks at application areas where it has made a significant impact.

Medtronic Gains Approval of First Artificial Pancreas Device System with Threshold Suspend Automation

September 27, 2013 10:19 am | by Medtronic | News | Comments

Medtronic, Inc. has announced the FDA approval of the MiniMed 530G with Enlite, a breakthrough, first-generation artificial pancreas system with Threshold Suspend automation for people with diabetes. Medtronic’s system is the first in the United States that can automatically stop insulin delivery when sensor glucose values reach a preset level...

Stryker, Medtronic lose preemption bids in OP-1, Calstrux and Infuse lawsuit

September 25, 2013 3:13 pm | by Mass Device | News | Comments

A California state court ruled out a series of motions seeking to dismiss a lawsuit filed over bone proteins made by Stryker and Medtronic, ruling that federal law does not preempt the case from going forward. April Cabana sued the medical device companies for alleged off-label promotion of the bone growth products...

FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries

September 24, 2013 11:42 am | by The Associated Press | News | Comments

Expanding its role in the treatment of peripheral artery disease in the United States, Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has approved the Complete SE (self-expanding) vascular stent for use in the lower extremities -- specifically, the superficial femoral artery (SFA) and proximal popliteal artery (PPA), which carry blood through the upper legs.

Medtronic pays $290k to settle wage discrimination lawsuit

September 24, 2013 7:59 am | by Mass Device | News | Comments

Minnesota medical device company Medtronic is closing the books on a years-old wage discrimination case, paying $290,000 to settle claims that it paid Hispanic workers less than white workers. Filed by the U.S. Dept. of Labor, the lawsuit claimed that Medtronic shortchanged 78 Hispanic entry-level employees at a Danvers, Mass., facility.

Reduced Risk of Atrial Fibrillation for Patients with Medtronic’s AdaptivCRT

September 23, 2013 11:14 am | by Medtronic | News | Comments

Medtronic, Inc. has announced clinical trial results showing that heart failure patients treated with its exclusive AdaptivCRT feature experienced a nearly 50 percent reduction in atrial fibrillation (AF) risk. Pioneered by Medtronic, the AdaptivCRT technology is a feature on certain cardiac resynchronization therapy-defibrillators...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading